Back to search

Article

Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in Systemic Lupus Erythematosus

2024-08-04

Abstract excerpt

<h4>Objective</h4> We aim to explore the role of mechanistic target of rapamycin complex (mTORC) 2 in systemic lupus erythematosus (SLE) development, the in vivo regulation of mTORC2 by type I interferon (IFN) signaling in autoimmunity, and to use mTORC2 targeting therapy to ameliorate lupus-like symptoms in an in vivo lupus mouse model and an in vitro coculture model using human PBMCs. <h4>Method</h4> We fi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee1a0962-c1f9-5171-9903-61e6ae873d48
DOI
10.1101/2024.08.01.606069
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in Systemic Lupus ErythematosusDOI 10.1101/2024.08.01.606069
Select a neighboring publication to make it the new centre.